Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "warns sterilization plant closures could bring device shortages" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about warns sterilization plant closures could bring device shortages for you to read. Along with our medical data and news we also list warns sterilization plant closures could bring device shortages Clinical Trials, which are updated daily. BioPortfolio also has a large database of warns sterilization plant closures could bring device shortages Companies for you to search.
Cerus Endovascular has announced that it has received European CE Mark approval for its lead product, the Contour Neurovascular System, for the treatment of intracranial aneurysms. International Approvals
ClinOne announces today its strategic collaboration with BioIntelliSense to combine continuous health monitoring and clinical intelligence with the ClinOne ClinTrialConnect™ patient portal platform. The addition of the FDA-cleared BioSticker™ single-use device provides an effortless trial participant experience enabling 30-days of continuous vital sign monitoring
PinnacleCare Members Now Have Access to Leading Medical Expertise Via the Summus Telehealth Platform PinnacleCare, the premier health advisory firm, and Summus Global, a leading virtual health advisory company, today announced an exclusive
Leading Medical Technology and Communications Companies Join the RapidAI Technology Partner Program RapidAI, the worldwide leader in advanced imaging for stroke, today announced the launch of the RapidAI Technology Partner Program, an ecosystem of technologies that complement or integrate with the Rapid platform. In tandem, the company also released a new RapidAI API (Application Programming Int...
Boehringer Ingelheim offers MyStudyWindow to provide patients, families, caregivers, and doctors consistent access to information about Boehringer Ingelheim’s actively recruiting studies conducted at global site locations The platform features patient-centric study titles and descriptions, educational content, and guidance on the clinical trial selection and enrollment process Anonymous co...
Coverage Enables TRICARE Beneficiaries With Psoriasis and Eczema to Access the Clarify Home Phototherapy System The Clarify System’s Patented Technology Enables Patients to Treat at Home or While Traveling With the Same Level of Control and Care That They Receive in the Clinic Clarify Medical today announced that the Clarify Home Phototherap
Arrevus, a clinical stage biopharmaceutical company committed to the development of innovative therapies to treat orphan or serious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ARV-1801 for the treatment of cystic fibrosis (CF). Orphan Drug Designation provides for close guidance by the FDA, potentially accelerating time to mark...
Rothenhaus’ expertise to help Current Health scale its patient management platform across the U.S. Current Health, which offers the leading FDA-cleared, artificial intelligence (AI)-powered remote patient management platform, today announced it has appointed healthcare industry v
− State-of-the art equipment to increase production efficiency and output for U.S.-based Mo-99 supply − NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved the addition of two molybdenum-99 (Mo-99) filling lines at its facility in Co...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in March: Cowen and Company 40th Annual Health Care Conference Date: Tuesday, Mar. 3, 2020 Presentation Time: 12 p.m. ET Location: Boston The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics...
In this free webinar devoted to radiopharmaceuticals, the featured speakers will explore the scientific, operational and regulatory considerations for radiopharmaceuticals. With a focus on oncology, they will discuss the current regulatory landscape and how this impacts overall development programs. The speakers will explore the challenges of conducting radiopharmaceutical trials, offering insight...
Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced today it had achieved significant progress with the U.S. FDA in restarting its efforts for sales and marketing approval of its LuViva Advanced Cervical Scan. After a succession of conference calls, emails and letters exchanged with...
CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, announced the completion of a US$98 million Series D financing. The round was led by General Atlantic, a leading global growth equity firm, and WuXi AppTec. Each firm also has the option to invest up to an additional $10 million, upo...
The company is the first EHR vendor to have a fully web-based nursing solution MEDITECH has disrupted the EHR market with its revolutionary physician mobility tools, and now the company is doing it again for nurses and therapists with Expanse Patient Care. The intuitive, web-based software empowers nurses an
Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) today announced the launch of its new CBD CLINIC Massage Therapy Series, a line of eight new massage oils and creams. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200218005600/en/
Industry veteran Arun Ananthapadmanabhan joins as Executive Vice President, Global Growth Proscia, a leading provider of artificial intelligence (AI) enabled digital pathology solutions, has expanded into the international diagnostic pathology market to meet the growing needs of laboratories and cancer patients worldwide. The company has added the leadership of Arun Ananthapadmanabhan as Executi...
SummaryThe global AntiScale Systems market will reach xxx Million USD in 2020 with CAGR xx% 20202025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers profile, products services, sales data of businessGlobal market size by Major EndUseGlobal market size by Major TypeKey manufacturers are included bas...
BioVentrix, Inc., a pioneer of technologies and procedures for the less invasive treatment of heart failure (HF), today announced that Gregg Stone, MD, of New York’s Mount Sinai Health System has signed on to the pivotal
-- The PATHFINDER Study will Return GRAIL’s Test Results to Providers for the First Time -- -- First Participants Successfully Enrolled -- -- FDA Approves IDE for GRAIL’s Test -- GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced the initiation of the PATHFINDER Study. A prospective, multi-center study, PATHFINDER marks the fi...
Scientists at the University of Massachusetts Amherst have developed a device that uses a natural
The agency postponed drug and device inspections in China that were scheduled for February, limiting its oversight of a key country in the medical supply chain.
Acquired product line is strong complement to the company’s leading Advanced Surgery portfolio Global integration process begins immediately to manage successful transition with customers and distributors Baxter International Inc. (NYSE:BAX), a leading global medical products company, has completed its
Rheos Medicines, a biopharmaceutical company harnessing insights in immunometabolism to create a new class of therapeutics for patients with severe autoimmune disorders, inflammatory diseases and cancer, today announced that Barbara S. Fox, Ph.D., the Company’s Chief Executive Officer, will present at the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020 at 10:00 a....
22nd Century Group and FDA presented information regarding 22nd Century’s Modified Risk Tobacco Product marketing application for its proprietary VLN® and VLN® Menthol Reduced Nicotine Content Cigarettes 22nd Century Group, Inc. (NYSE American: XXII) — a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis plant research — met on
India has proposed three categories for grouping genetically edited organisms based on the complexity of modifications.